This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fudan University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Jintong Yang: Innovator in Pharmaceutical Compounds
Introduction
Jintong Yang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various health issues. His innovative work has led to the creation of a patent that holds promise for treating several diseases.
Latest Patents
Jintong Yang holds a patent for an "Alkoxybenzo-five-membered (six-membered) heterocyclic amine compound and pharmaceutical use thereof." This patent involves alkoxybenzeno five- or six-member heterocyclic amines compounds, their pharmaceutically acceptable salts, and pharmaceutical compositions. These compounds serve as active ingredients in drugs designed to prevent and cure diseases caused by the abnormal increase of SM. The diseases targeted by this innovation include atherosclerosis, type II diabetes, fatty liver, obesity, metabolic syndromes, enteritis, and other inflammatory diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Jintong Yang has worked with esteemed institutions such as Fudan University and Shijiazhuang Yiling Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Mingguang Mo and Deyong Ye. Their collaborative efforts have further advanced the research and development of pharmaceutical compounds.
Conclusion
Jintong Yang's innovative work in pharmaceutical compounds showcases his dedication to addressing critical health issues. His contributions through patents and collaborations highlight the importance of research in developing effective treatments for various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
